Human Trials

What are monoclonal antibodies ? Why do we need them as well as a COVID-19 vaccine?

The FDA issued emergency use authorization for Eli Lilly’s monoclonal antibody while Regeneron is still awaiting the FDA’s green light for its antibody treatment.

Volunteers to be exposed to COVID-19 virus to find the amount of virus it take to infect a person

The volunteer would be infected via the nose and the results will be used to study how vaccines might work and to explore potential treatments.

DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine

RDIF will also supply 100 million doses of Dr Reddy's after receiving Indian regulatory approval.

Under fire for vaccine safety, AstraZeneca releases 111-page human trial blueprint

The company has released few details about the two cases of serious illness in its trial.

RDIF, Dr Reddy's Lab tie up for Sputnik V human trials, distribution of 100 mn doses of the COVID-19 vaccine in India

As of 1 August, Phase I and II of the vaccine were complete and by 11 August, Russian President Vladimir Putin had registered it as the world's first vaccine.

UAE announces emergency use of COVID-19 vaccine that is still in its final testing, for healthcare workers

Chinese drug giant Sinopharm began the third phase of trials for a Covid-19 vaccine in the UAE in July, with Emirati officials saying the results have been positive.

Elon Musk demonstrates how a Neuralink chip brain implant works – in a pig

Matthew MacDougall, a neurosurgeon that works with Neuralink, they were considering implanting the chip in a paralyzed person so that they could type on a computer or form words.

Russia and India in talks about manufacturing deal for Russia's COVID-19 vaccine Sputnik V

Russia 'Sputnik V' vaccine promises to help people develop immunity against COVID-19 for two years: Here's all you need to know

Sputnik V can only be used on people within the age groups of 18-60 as more studies need to ensure the vaccine is safe for older people.

Russia's COVID-19 vaccine to enter production, deliver first batch of doses in two weeks

The vaccine is given in two doses and will help people develop immunity to the virus for at least two years.